FTC takes aim at deceptive stem cell therapy claims

People spend billions of dollars each year on health-related products and treatments that don’t deliver. People who buy them are cheated out of their money, their time, and even their health.

The FTC says that California-based Regenerative Medical Group, Telehealth Medical Group, and Dr. Bryn Jarald Henderson, the founder of both companies, sold false hope at high prices.

These companies and Dr. Henderson used social media and websites to promote stem cell therapy for all kinds of health issues affecting older adults and children. Supposedly, it could treat and cure diseases and health conditions such as Parkinson’s disease, autism, dementia, depression, multiple sclerosis, cerebral palsy, traumatic brain injury, heart disease, macular degeneration, chronic kidney disease, osteoarthritis, and stroke. Defendants charged up to $15,000 for their initial stem cell therapy and up to $8,000 for follow-up treatments.

But, according to the FTC, these claims were not backed up by any scientific studies and, in fact, no studies have established that stem cells cure, treat, or reduce the severity of diseases or health conditions in humans. With the exception of a few FDA-approved treatments, stem cell therapy is still largely experimental.

Under the proposed settlement, the defendants can no longer make these claims, and they have to pay more than $500,000 in refunds to consumers.

Are you — or someone you know — thinking about stem cell therapy?

• Be skeptical about amazing health claims.
• Don’t trust a website just because it looks professional, uses medical terms, or has success stories from “real people.”
• Talk to your health care professional before you consider any medical treatment.

For more information, see Buying Health Products and Services Online. If you think you’ve spotted health-related fraud, report it to the FTC.

Where this page came from

This page was imported from Federal Trade Commission. Published by the Federal Trade Commission and, as a work of the United States government, in the public domain; material credited to others is left out.

Nobody has written it yet — it is the source material at a new address, which is why search engines are asked to skip it and why no one earns from it. It is up for grabs: take it on, and it is yours to rewrite and to earn from.